Skip to main content
ICRweb
About Issuing Certificates

ICR Contents

Regulatory Guidelines
All Contents
  • Fresh Insights Playlist
    • [Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV
    • [Part 2] HIV associated malignancies: Malignancy in People Living with HIV
    • [Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV
    • [Part 4] Discussion : Malignancy in People Living with HIV
    • [Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer
    • [Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer
    • [Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer
    • [Part 4]Discussion: Lung Cancer
  • Fresh Insights Playlist
    • [Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV
    • [Part 2] HIV associated malignancies: Malignancy in People Living with HIV
    • [Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV
    • [Part 4] Discussion : Malignancy in People Living with HIV
    • [Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer
    • [Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer
    • [Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer
    • [Part 4]Discussion: Lung Cancer
  • Recommended Lectures
    • Cancer Biology and Molecular Biology
    • Sample handling
    • Procedures and Interpretation of Next Generation Sequencing Results
    • Methods of utilizing NGS test results (off-label, clinical trial, etc.)
    • ISO 15189 accreditation program for molecular-genetic laboratories
    • Basic Knowledge and Practical Consideration of Phase I Trials in Oncology
    • The General Role Of CRCs In Cancer Clinical Trials
    • Review of cancer clinical trial protocols from a CRC perspective
    • Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2
    • Designs for clinical trials on cancer - Part 1 of 2
What is ICRweb? What is ATLAS? FAQ Contact
ICRweb
  • About ICRweb
  • What is ATLAS?
  • FAQ
  • Contact
  • Japanese
  • You are not logged in. (Log in)

ICR臨床研究入門

  1. Home
  2. ICRweb
  3. 規制ガイドライン
  • 指針
  • 臨床研究法・先進医療
  • GCP
  • 国内外の動向
  • 海外倫理ガイドライン

指針

  • 人を対象とする生命科学・医学系研究
  • 遺伝子治療臨床研究
  • 遺伝子組換え実験

臨床研究法・先進医療

  • 臨床研究法について｜厚生労働省
  • 先進医療

GCP

  • 医薬品
  • 治験届関係
  • 副作用等報告関係
  • 対面助言・審査関係
  • 医療機器
  • 不具合等報告関係
  • 再生医療等

日本の動向

【がん対策関連】

  • がん対策推進基本計画

【研究推進関連（がん以外も含む）】

  • 内閣官房 健康・医療戦略室　健康・医療戦略推進本部
  • 臨床研究・治験の活性化について
  • 科学技術基本計画及び科学技術・イノベーション基本計画
  • 国立研究開発法人 日本医療研究開発機構（AMED）
  • AMED研究開発課題データベース
  • 製薬協（日本製薬工業協会）
  • 一般社団法人 PPI JAPAN

海外の動向

【米国】

  • National Institutes of Health (NIH)

海外ガイドライン

  • ヘルシンキ宣言
  • ベルモントレポート（英文）
  • ベルモントレポート（和文）
  • ニュルンベルク綱領（原文）
  • ニュルンベルク綱領（日本語）
  • CIOMS
  • 45CFR46
◄ ICRwebのご紹介
よくあるご質問 ►

Introduction to Clinical Research

  • Top Page
  • What is ICRweb
  • Regulatory Guidelines
  • FAQ
  • Contact Us

Course List

Course List
  • Cancer Genomic Medicine: Essential Course
  • Cancer Genomic Medicine: the Practice in Japan
  • ISO 15189 Accreditation Support Course
  • Phase 1 Trial Development Course
  • CRC Training Course
  • Outline of Clinical Trials on Cancer
  • ATLAS International Symposium
  • SICRES seminar
  • ATLAS Monthly Webinar
  • Site Policy

Copyright © 2007-2024 ICRweb all rights reserved.